Glutamate carboxypeptidase II (NAALADase) inhibition as a novel therapeutic strategy.
about
Carboxypeptidase O is a glycosylphosphatidylinositol-anchored intestinal peptidase with acidic amino acid specificityCharacterization of carboxypeptidase A6, an extracellular matrix peptidaseNAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia.Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide familyNAAG peptidase inhibitors and deletion of NAAG peptidase gene enhance memory in novel object recognition test.Prostate-specific membrane antigen can promote in vivo osseous metastasis of prostate cancer cells in miceCurrent approaches with the glutamatergic system as targets in the treatment of neuropathic pain.The prostate-specific membrane antigen: lessons and current clinical implications from 20 years of research.NAAG Peptidase Inhibitors Act via mGluR3: Animal Models of Memory, Alzheimer's, and Ethanol Intoxication.N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC: a new imaging probe for prostate cancer.Current and emerging treatments for amyotrophic lateral sclerosis.
P2860
Q28115334-5DAB84C0-CE5F-4209-ACDD-BFDCE571217AQ28263785-5E8BD750-5065-42D4-85CF-8D0747688076Q30465008-D263DA96-90BF-43D4-9AA8-02C28D1F8B58Q30465259-2AF4EDCD-1D39-4754-A0FB-7DE90E18506BQ36675499-DB11891C-4486-458A-9776-6F17223261E1Q37371051-FB152689-8655-444B-9FE9-346963AB41D0Q37523991-4BA48297-3494-4A30-B8F2-C02DA41A9340Q38169828-354FD1BE-4169-47AB-A1C8-54DDED720B50Q38912835-BDDF2E97-D51B-4562-9B07-2AF68ED511D4Q41913170-D5885BFD-1A57-4FAA-B3A9-32FF22DCA258Q42685032-57E5CD32-A511-40F2-AE60-F8B5C375F580
P2860
Glutamate carboxypeptidase II (NAALADase) inhibition as a novel therapeutic strategy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Glutamate carboxypeptidase II (NAALADase) inhibition as a novel therapeutic strategy.
@ast
Glutamate carboxypeptidase II (NAALADase) inhibition as a novel therapeutic strategy.
@en
type
label
Glutamate carboxypeptidase II (NAALADase) inhibition as a novel therapeutic strategy.
@ast
Glutamate carboxypeptidase II (NAALADase) inhibition as a novel therapeutic strategy.
@en
prefLabel
Glutamate carboxypeptidase II (NAALADase) inhibition as a novel therapeutic strategy.
@ast
Glutamate carboxypeptidase II (NAALADase) inhibition as a novel therapeutic strategy.
@en
P2093
P356
P1476
Glutamate carboxypeptidase II (NAALADase) inhibition as a novel therapeutic strategy.
@en
P2093
Ajit G Thomas
Barbara S Slusher
Camilo Rojas
David Calvin
James Vornov
Krystyna M Wozniak
Takashi Tsukamoto
P304
327-37; discussion 361-3
P356
10.1007/0-387-30172-0_24
P407
P577
2006-01-01T00:00:00Z